Cargando…
Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells
BACKGROUND: Mesenchymal stem cells (MSCs) have been demonstrated to be effective in treating autoimmune diseases including Sjögren’s syndrome (SS). We aim to compare the effects of MSC transplantation (MSCT) and the role of serum interleukin-12 (IL-12) in SS. METHODS: IL-12 levels were measured by E...
Autores principales: | Shi, Bingyu, Qi, Jingjing, Yao, Genhong, Feng, Ruihai, Zhang, Zhuoya, Wang, Dandan, Chen, Chen, Tang, Xiaojun, Lu, Liwei, Chen, Wanjun, Sun, Lingyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225717/ https://www.ncbi.nlm.nih.gov/pubmed/30409219 http://dx.doi.org/10.1186/s13287-018-1023-x |
Ejemplares similares
-
Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis
por: Yao, Genhong, et al.
Publicado: (2019) -
IL-27 Regulated CD4(+)IL-10(+) T Cells in Experimental Sjögren Syndrome
por: Qi, Jingjing, et al.
Publicado: (2020) -
Umbilical cord mesenchymal stem cells alleviate Sjögren’s syndrome and related pulmonary inflammation through regulating Vγ4(+) IL-17(+) T cells
por: Cong, Yan, et al.
Publicado: (2022) -
Mesenchymal Stem Cells Control Complement C5 Activation by Factor H in Lupus Nephritis
por: Ma, Haijun, et al.
Publicado: (2018) -
Mesenchymal stem cell therapy induces FLT3L and CD1c(+) dendritic cells in systemic lupus erythematosus patients
por: Yuan, Xinran, et al.
Publicado: (2019)